Advertisement

Index by Author

November 1997; 46 (11)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ader, M

    • Reassessment of glucose effectiveness and insulin sensitivity from minimal model analysis: a theoretical evaluation of the single-compartment glucose distribution assumption. Diabetes November 1997 46:1813-1821; doi:10.2337/diabetes.46.11.1813

  2. Adojaan, B

    • The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes November 1997 46:1888-1892; doi:10.2337/diabetes.46.11.1888

  3. Akerblom, H K

    • The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes November 1997 46:1888-1892; doi:10.2337/diabetes.46.11.1888

  4. Andersen, J L

    • Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes November 1997 46:1822-1828; doi:10.2337/diabetes.46.11.1822

  5. Andersen, R

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  6. Anderson, R A

    • Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes November 1997 46:1786-1791; doi:10.2337/diabetes.46.11.1786

  7. Araki, S

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  8. Arch, J

    • Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes November 1997 46:1782-1785; doi:10.2337/diabetes.46.11.1782

  9. Asahi, Y

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

B

  1. Bédard, S

    • Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes November 1997 46:1691-1700; doi:10.2337/diabetes.46.11.1691

  2. Bell, G I

    • Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene. Diabetes November 1997 46:1749-1754; doi:10.2337/diabetes.46.11.1749

  3. Berden, J H

    • Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes November 1997 46:1875-1880; doi:10.2337/diabetes.46.11.1875

  4. Bereczki, D

    • Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes November 1997 46:1840-1845; doi:10.2337/diabetes.46.11.1840

  5. Bergman, R N

    • Reassessment of glucose effectiveness and insulin sensitivity from minimal model analysis: a theoretical evaluation of the single-compartment glucose distribution assumption. Diabetes November 1997 46:1813-1821; doi:10.2337/diabetes.46.11.1813

  6. Bilinski, D

    • Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes November 1997 46:1805-1812; doi:10.2337/diabetes.46.11.1805

  7. Bingley, P J

    • Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes November 1997 46:1701-1710; doi:10.2337/diabetes.46.11.1701

  8. Björntorp, P

    • Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats. Diabetes November 1997 46:1799-1804; doi:10.2337/diabetes.46.11.1799

  9. Bonifacio, E

    • Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes November 1997 46:1701-1710; doi:10.2337/diabetes.46.11.1701

  10. Bottazzo, G F

    • Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes November 1997 46:1701-1710; doi:10.2337/diabetes.46.11.1701

  11. Brendel, M D

    • Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes November 1997 46:1907-1910; doi:10.2337/diabetes.46.11.1907

  12. Bretzel, R G

    • Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes November 1997 46:1907-1910; doi:10.2337/diabetes.46.11.1907

  13. Brunner, L

    • Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes November 1997 46:1792-1798; doi:10.2337/diabetes.46.11.1792

  14. Bryden, N A

    • Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes November 1997 46:1786-1791; doi:10.2337/diabetes.46.11.1786

  15. Buckingham, R

    • Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes November 1997 46:1782-1785; doi:10.2337/diabetes.46.11.1782

  16. Burn, P

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

C

  1. Camilleri, S

    • Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes November 1997 46:1768-1774; doi:10.2337/diabetes.46.11.1768

  2. Campfield, L A

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

  3. Capeau, J

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  4. Caron, M

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  5. Carvalho, G

    • Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes November 1997 46:1805-1812; doi:10.2337/diabetes.46.11.1805

  6. Cheng, N

    • Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes November 1997 46:1786-1791; doi:10.2337/diabetes.46.11.1786

  7. Cheskin, L J

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  8. Chi, J

    • Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes November 1997 46:1786-1791; doi:10.2337/diabetes.46.11.1786

  9. Chisholm, D J

    • Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes November 1997 46:1768-1774; doi:10.2337/diabetes.46.11.1768

  10. Chung, W K

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  11. Cohen, A

    • TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes November 1997 46:1678-1683; doi:10.2337/diabetes.46.11.1678

  12. Cooney, G J

    • Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes November 1997 46:1768-1774; doi:10.2337/diabetes.46.11.1768

  13. Copeland, J G

    • The blood contribution to early myocardial reperfusion injury is amplified in diabetes. Diabetes November 1997 46:1859-1867; doi:10.2337/diabetes.46.11.1859

  14. Côté, C H

    • Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes November 1997 46:1691-1700; doi:10.2337/diabetes.46.11.1691

  15. Cotroneo, P

    • Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes November 1997 46:1853-1858; doi:10.2337/diabetes.46.11.1853

  16. Cresci, B

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

  17. Criscione, L

    • Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes November 1997 46:1792-1798; doi:10.2337/diabetes.46.11.1792

  18. Csiba, L

    • Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes November 1997 46:1840-1845; doi:10.2337/diabetes.46.11.1840

  19. Cumin, F

    • Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes November 1997 46:1792-1798; doi:10.2337/diabetes.46.11.1792

D

  1. Deckert, T

    • Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes November 1997 46:1875-1880; doi:10.2337/diabetes.46.11.1875

  2. Desbois-Mouthon, C

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  3. Diepolder, C

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  4. Di Mario, U

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

  5. Dobashi, Y

    • GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner. Diabetes November 1997 46:1755-1760; doi:10.2337/diabetes.46.11.1755

  6. Donaghue, V M

    • Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes November 1997 46:1846-1852; doi:10.2337/diabetes.46.11.1846

  7. Donahey, J C

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

  8. Drinkgern, J

    • Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes November 1997 46:1733-1742; doi:10.2337/diabetes.46.11.1733

E

  1. Eckhard, M

    • Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes November 1997 46:1907-1910; doi:10.2337/diabetes.46.11.1907

  2. Eichler, H G

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  3. Elahi, D

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  4. Elberg, G

    • Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes. Diabetes November 1997 46:1684-1690; doi:10.2337/diabetes.46.11.1684

  5. Etgen, G J, Jr

    • Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes November 1997 46:1915-1919; doi:10.2337/diabetes.46.11.1915

F

  1. Fajans, S S

    • Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene. Diabetes November 1997 46:1749-1754; doi:10.2337/diabetes.46.11.1749

  2. Fasching, P

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  3. Feng, J

    • Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes November 1997 46:1786-1791; doi:10.2337/diabetes.46.11.1786

  4. Fielding, R A

    • Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes November 1997 46:1846-1852; doi:10.2337/diabetes.46.11.1846

  5. Findl, O

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  6. Fisher, S J

    • Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes November 1997 46:1805-1812; doi:10.2337/diabetes.46.11.1805

  7. Fryburg, D A

    • Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes November 1997 46:1915-1919; doi:10.2337/diabetes.46.11.1915

  8. Fülesdi, B

    • Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes November 1997 46:1840-1845; doi:10.2337/diabetes.46.11.1840

G

  1. Gale, E A

    • Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes November 1997 46:1701-1710; doi:10.2337/diabetes.46.11.1701

  2. Gallenkamp, A

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  3. Galli, G

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

  4. Garbarsch, C

    • Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes November 1997 46:1875-1880; doi:10.2337/diabetes.46.11.1875

  5. Genovese, S

    • Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes November 1997 46:1701-1710; doi:10.2337/diabetes.46.11.1701

  6. Gerald, C

    • Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes November 1997 46:1792-1798; doi:10.2337/diabetes.46.11.1792

  7. Ghirlanda, G

    • Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes November 1997 46:1853-1858; doi:10.2337/diabetes.46.11.1853

  8. Giacca, A

    • Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes November 1997 46:1805-1812; doi:10.2337/diabetes.46.11.1805

  9. Giannini, S

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

  10. Giardina, B

    • Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes November 1997 46:1853-1858; doi:10.2337/diabetes.46.11.1853

  11. Gibbs, E M

    • Nitric oxide stimulates skeletal muscle glucose transport through a calcium/contraction- and phosphatidylinositol-3-kinase-independent pathway. Diabetes November 1997 46:1915-1919; doi:10.2337/diabetes.46.11.1915

  12. Giurini, J M

    • Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes November 1997 46:1846-1852; doi:10.2337/diabetes.46.11.1846

  13. Glaser, B

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  14. Gonoi, T

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  15. Gravholt, C H

    • Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes November 1997 46:1822-1828; doi:10.2337/diabetes.46.11.1822

H

  1. Hadjiathanasiou, C G

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  2. Halban, P A

    • Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes November 1997 46:1725-1732; doi:10.2337/diabetes.46.11.1725

  3. Halter, J B

    • Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene. Diabetes November 1997 46:1749-1754; doi:10.2337/diabetes.46.11.1749

  4. Han, D H

    • Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes November 1997 46:1761-1767; doi:10.2337/diabetes.46.11.1761

  5. Hansen, B F

    • Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes November 1997 46:1775-1781; doi:10.2337/diabetes.46.11.1775

  6. Hansen, P A

    • Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes November 1997 46:1761-1767; doi:10.2337/diabetes.46.11.1761

  7. Hansen, P M

    • Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes November 1997 46:1875-1880; doi:10.2337/diabetes.46.11.1875

  8. Hering, B J

    • Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes November 1997 46:1907-1910; doi:10.2337/diabetes.46.11.1907

  9. Herman, W H

    • Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene. Diabetes November 1997 46:1749-1754; doi:10.2337/diabetes.46.11.1749

  10. He, Z

    • Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes. Diabetes November 1997 46:1684-1690; doi:10.2337/diabetes.46.11.1684

  11. Higo, K

    • TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes November 1997 46:1678-1683; doi:10.2337/diabetes.46.11.1678

  12. Hirashima, T

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  13. Hofbauer, K G

    • Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes November 1997 46:1792-1798; doi:10.2337/diabetes.46.11.1792

  14. Hokama, J Y

    • The blood contribution to early myocardial reperfusion injury is amplified in diabetes. Diabetes November 1997 46:1859-1867; doi:10.2337/diabetes.46.11.1859

  15. Holloszy, J O

    • Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes November 1997 46:1761-1767; doi:10.2337/diabetes.46.11.1761

  16. Holmäng, A

    • Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats. Diabetes November 1997 46:1799-1804; doi:10.2337/diabetes.46.11.1799

  17. Horton, E S

    • Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes November 1997 46:1846-1852; doi:10.2337/diabetes.46.11.1846

  18. Host, H H

    • Insulin resistance of muscle glucose transport in rats fed a high-fat diet: a reevaluation. Diabetes November 1997 46:1761-1767; doi:10.2337/diabetes.46.11.1761

  19. Høyer, P E

    • Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes November 1997 46:1875-1880; doi:10.2337/diabetes.46.11.1875

I

  1. Ilonen, J

    • The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes November 1997 46:1888-1892; doi:10.2337/diabetes.46.11.1888

  2. Inagaki, N

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

J

  1. Jaeger, C

    • Progressive islet graft failure occurs significantly earlier in autoantibody-positive than in autoantibody-negative IDDM recipients of intrahepatic islet allografts. Diabetes November 1997 46:1907-1910; doi:10.2337/diabetes.46.11.1907

  2. James, D E

    • Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles. Diabetes November 1997 46:1667-1677; doi:10.2337/diabetes.46.11.1667

  3. Jensen, T

    • Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes November 1997 46:1875-1880; doi:10.2337/diabetes.46.11.1875

K

  1. Kaal, A

    • Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes November 1997 46:1822-1828; doi:10.2337/diabetes.46.11.1822

  2. Kahn, S E

    • Release of incompletely processed proinsulin is the cause of the disproportionate proinsulinemia of NIDDM. Diabetes November 1997 46:1725-1732; doi:10.2337/diabetes.46.11.1725

  3. Kanno, T

    • GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner. Diabetes November 1997 46:1755-1760; doi:10.2337/diabetes.46.11.1755

  4. Kapur, S

    • Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes November 1997 46:1691-1700; doi:10.2337/diabetes.46.11.1691

  5. Karayanni, C

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  6. Kasuga, M

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  7. Kawanishi, M

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  8. Kawano, K

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  9. Kiens, B

    • Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes November 1997 46:1775-1781; doi:10.2337/diabetes.46.11.1775

  10. Kistler, J A

    • Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes November 1997 46:1846-1852; doi:10.2337/diabetes.46.11.1846

  11. Kobayashi, Y

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

  12. Konda, S

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

  13. Kovalchuk, L

    • The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes November 1997 46:1888-1892; doi:10.2337/diabetes.46.11.1888

  14. Kraegen, E W

    • Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes November 1997 46:1768-1774; doi:10.2337/diabetes.46.11.1768

  15. Kubota, T

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  16. Kulczycki, A, Jr

    • Cow's milk-free diet does not prevent diabetes in NOD mice. Diabetes November 1997 46:1711-1717; doi:10.2337/diabetes.46.11.1711

L

  1. Landau, H

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  2. Legemate, D

    • Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes November 1997 46:1840-1845; doi:10.2337/diabetes.46.11.1840

  3. Leibel, R L

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  4. Lekas, M

    • Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes November 1997 46:1805-1812; doi:10.2337/diabetes.46.11.1805

  5. Lenzen, S

    • Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes November 1997 46:1733-1742; doi:10.2337/diabetes.46.11.1733

  6. Li, J

    • Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes. Diabetes November 1997 46:1684-1690; doi:10.2337/diabetes.46.11.1684

  7. Limburg, M

    • Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes November 1997 46:1840-1845; doi:10.2337/diabetes.46.11.1840

  8. Lönnroth, P

    • Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats. Diabetes November 1997 46:1799-1804; doi:10.2337/diabetes.46.11.1799

  9. Lortz, S

    • Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes November 1997 46:1733-1742; doi:10.2337/diabetes.46.11.1733

M

  1. Magré, J

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  2. Manto, A

    • Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes November 1997 46:1853-1858; doi:10.2337/diabetes.46.11.1853

  3. Man, Z W

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  4. Marcotte, B

    • Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes November 1997 46:1691-1700; doi:10.2337/diabetes.46.11.1691

  5. Marette, A

    • Expression of nitric oxide synthase in skeletal muscle: a novel role for nitric oxide as a modulator of insulin action. Diabetes November 1997 46:1691-1700; doi:10.2337/diabetes.46.11.1691

  6. Marra, G

    • Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes November 1997 46:1853-1858; doi:10.2337/diabetes.46.11.1853

  7. Martorana, G E

    • Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes November 1997 46:1853-1858; doi:10.2337/diabetes.46.11.1853

  8. Masugi, J

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  9. McDonagh, P F

    • The blood contribution to early myocardial reperfusion injury is amplified in diabetes. Diabetes November 1997 46:1859-1867; doi:10.2337/diabetes.46.11.1859

  10. Meier, M

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  11. Mené, P

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

  12. Mensik, C

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  13. Michels, R P

    • Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes November 1997 46:1840-1845; doi:10.2337/diabetes.46.11.1840

  14. Miles, P D

    • TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes November 1997 46:1678-1683; doi:10.2337/diabetes.46.11.1678

  15. Mimura, K

    • Interstitial muscle insulin and glucose levels in normal and insulin-resistant Zucker rats. Diabetes November 1997 46:1799-1804; doi:10.2337/diabetes.46.11.1799

  16. Minamitani, K

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

  17. Miyamoto, S

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

  18. Mizuno, A

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  19. Mordente, A

    • Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes November 1997 46:1853-1858; doi:10.2337/diabetes.46.11.1853

  20. Mori, H

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  21. Mori, S

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  22. Muller, D

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  23. Müller, M

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  24. Mullooly, C A

    • Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes November 1997 46:1846-1852; doi:10.2337/diabetes.46.11.1846

  25. Murata, A

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

N

  1. Nakano, K

    • GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner. Diabetes November 1997 46:1755-1760; doi:10.2337/diabetes.46.11.1755

  2. Nejentsev, S

    • The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes November 1997 46:1888-1892; doi:10.2337/diabetes.46.11.1888

  3. Nestorowicz, A

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  4. Neuwirth, G

    • Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes November 1997 46:1840-1845; doi:10.2337/diabetes.46.11.1840

  5. Niimi, H

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

  6. Niki, T

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  7. Ni, T C

    • Reassessment of glucose effectiveness and insulin sensitivity from minimal model analysis: a theoretical evaluation of the single-compartment glucose distribution assumption. Diabetes November 1997 46:1813-1821; doi:10.2337/diabetes.46.11.1813

  8. Noma, Y

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  9. Nyholm, B

    • Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes November 1997 46:1822-1828; doi:10.2337/diabetes.46.11.1822

O

  1. Oakes, N D

    • Mechanisms of liver and muscle insulin resistance induced by chronic high-fat feeding. Diabetes November 1997 46:1768-1774; doi:10.2337/diabetes.46.11.1768

  2. Okazawa, H

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  3. Olefsky, J M

    • TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes November 1997 46:1678-1683; doi:10.2337/diabetes.46.11.1678

P

  1. Parikh, V V

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  2. Paxson, J A

    • Cow's milk-free diet does not prevent diabetes in NOD mice. Diabetes November 1997 46:1711-1717; doi:10.2337/diabetes.46.11.1711

  3. Pedersen, S B

    • Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes November 1997 46:1822-1828; doi:10.2337/diabetes.46.11.1822

  4. Permutt, M A

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  5. Polansky, M M

    • Elevated intakes of supplemental chromium improve glucose and insulin variables in individuals with type 2 diabetes. Diabetes November 1997 46:1786-1791; doi:10.2337/diabetes.46.11.1786

  6. Polonsky, K S

    • Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene. Diabetes November 1997 46:1749-1754; doi:10.2337/diabetes.46.11.1749

  7. Pricci, F

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

  8. Pugliese, F

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

  9. Pugliese, G

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

Q

  1. Qu, Z

    • Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes November 1997 46:1822-1828; doi:10.2337/diabetes.46.11.1822

R

  1. Rafaat, K

    • TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes November 1997 46:1678-1683; doi:10.2337/diabetes.46.11.1678

  2. Rea, S

    • Moving GLUT4: the biogenesis and trafficking of GLUT4 storage vesicles. Diabetes November 1997 46:1667-1677; doi:10.2337/diabetes.46.11.1667

  3. Reijonen, H

    • The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes November 1997 46:1888-1892; doi:10.2337/diabetes.46.11.1888

  4. Reynolds, J M

    • The blood contribution to early myocardial reperfusion injury is amplified in diabetes. Diabetes November 1997 46:1859-1867; doi:10.2337/diabetes.46.11.1859

  5. Richter, E A

    • Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes November 1997 46:1775-1781; doi:10.2337/diabetes.46.11.1775

  6. Romeo, G

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

  7. Romeo, O M

    • TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone. Diabetes November 1997 46:1678-1683; doi:10.2337/diabetes.46.11.1678

  8. Rotella, C M

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

S

  1. Sakamaki, T

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

  2. Saltin, B

    • Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes November 1997 46:1822-1828; doi:10.2337/diabetes.46.11.1822

  3. Sano, T

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  4. Santini, S A

    • Defective plasma antioxidant defenses and enhanced susceptibility to lipid peroxidation in uncomplicated IDDM. Diabetes November 1997 46:1853-1858; doi:10.2337/diabetes.46.11.1853

  5. Saouaf, R

    • Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes November 1997 46:1846-1852; doi:10.2337/diabetes.46.11.1846

  6. Sasaki, N

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

  7. Sato, T

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  8. Schaffhauser, A O

    • Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes November 1997 46:1792-1798; doi:10.2337/diabetes.46.11.1792

  9. Scheurink, A J

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

  10. Schmetterer, L

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  11. Schmitz, O

    • Evidence of an increased number of type IIb muscle fibers in insulin-resistant first-degree relatives of patients with NIDDM. Diabetes November 1997 46:1822-1828; doi:10.2337/diabetes.46.11.1822

  12. Schoor, K P

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  13. Schwartz, E I

    • The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes November 1997 46:1888-1892; doi:10.2337/diabetes.46.11.1888

  14. Seeley, R J

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

  15. Seino, S

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  16. Sekar, N

    • Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes. Diabetes November 1997 46:1684-1690; doi:10.2337/diabetes.46.11.1684

  17. Shechter, Y

    • Vanadate activates membranous nonreceptor protein tyrosine kinase in rat adipocytes. Diabetes November 1997 46:1684-1690; doi:10.2337/diabetes.46.11.1684

  18. Shima, K

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  19. Shinoda, H

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  20. Shi, Z Q

    • Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes November 1997 46:1805-1812; doi:10.2337/diabetes.46.11.1805

  21. Shuldiner, A R

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  22. Silver, K

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  23. Sinaniotis, C

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  24. Smith, M J

    • Diminished insulin and glucagon secretory responses to arginine in nondiabetic subjects with a mutation in the hepatocyte nuclear factor-4alpha/MODY1 gene. Diabetes November 1997 46:1749-1754; doi:10.2337/diabetes.46.11.1749

  25. Sochnevs, A

    • The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes November 1997 46:1888-1892; doi:10.2337/diabetes.46.11.1888

  26. Stanley, C A

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  27. Stavrinadis, C

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  28. Steffens, A B

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

  29. Strenn, K

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  30. Stricker-Krongrad, A

    • Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes November 1997 46:1792-1798; doi:10.2337/diabetes.46.11.1792

  31. Suga, S

    • GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner. Diabetes November 1997 46:1755-1760; doi:10.2337/diabetes.46.11.1755

  32. Sugihara, S

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

T

  1. Takeo, T

    • GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner. Diabetes November 1997 46:1755-1760; doi:10.2337/diabetes.46.11.1755

  2. Tamori, Y

    • No coding mutations are detected in the peroxisome proliferator-activated receptor-gamma gene in Japanese patients with lipoatrophic diabetes. Diabetes November 1997 46:1904-1906

  3. Tenenbaum, R

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

  4. Thiele, T E

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

  5. Thornton, P S

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  6. Tiedge, M

    • Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells. Diabetes November 1997 46:1733-1742; doi:10.2337/diabetes.46.11.1733

  7. Toide, K

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

  8. Tschernko, E

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

U

  1. Upton, R

    • Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes November 1997 46:1782-1785; doi:10.2337/diabetes.46.11.1782

V

  1. Valikovics, A

    • Impairment of cerebrovascular reactivity in long-term type 1 diabetes. Diabetes November 1997 46:1840-1845; doi:10.2337/diabetes.46.11.1840

  2. van den Born, J

    • Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes November 1997 46:1875-1880; doi:10.2337/diabetes.46.11.1875

  3. van Dijk, G

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

  4. Veves, A

    • Aerobic exercise capacity remains normal despite impaired endothelial function in the micro- and macrocirculation of physically active IDDM patients. Diabetes November 1997 46:1846-1852; doi:10.2337/diabetes.46.11.1846

  5. Vigouroux, C

    • Dominant transmission of insulin resistance in a type A family resulting from a heterozygous nonsense mutation in the insulin receptor gene and associated with decreased mRNA level and insulin binding sites. Diabetes November 1997 46:1901-1903

  6. Vlassara, H

    • Upregulation of mesangial growth factor and extracellular matrix synthesis by advanced glycation end products via a receptor-mediated mechanism. Diabetes November 1997 46:1881-1887; doi:10.2337/diabetes.46.11.1881

  7. Vranic, M

    • Insulin-independent acute restoration of euglycemia normalizes the impaired glucose clearance during exercise in diabetic dogs. Diabetes November 1997 46:1805-1812; doi:10.2337/diabetes.46.11.1805

W

  1. Wakui, M

    • GLP-I(7-36) amide augments Ba2+ current through L-type Ca2+ channel of rat pancreatic beta-cell in a cAMP-dependent manner. Diabetes November 1997 46:1755-1760; doi:10.2337/diabetes.46.11.1755

  2. Walston, J

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  3. Wataki, K

    • Association of HLA-DR, DQ genotype with different beta-cell functions at IDDM diagnosis in Japanese children. Diabetes November 1997 46:1893-1897; doi:10.2337/diabetes.46.11.1893

  4. Weber, J G

    • Cow's milk-free diet does not prevent diabetes in NOD mice. Diabetes November 1997 46:1711-1717; doi:10.2337/diabetes.46.11.1711

  5. Whitebread, S

    • Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides. Diabetes November 1997 46:1792-1798; doi:10.2337/diabetes.46.11.1792

  6. Widdowson, P S

    • Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes November 1997 46:1782-1785; doi:10.2337/diabetes.46.11.1782

  7. Wilkinson, C W

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

  8. Williams, A J

    • Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes November 1997 46:1701-1710; doi:10.2337/diabetes.46.11.1701

  9. Williams, G

    • Inhibition of food response to intracerebroventricular injection of leptin is attenuated in rats with diet-induced obesity. Diabetes November 1997 46:1782-1785; doi:10.2337/diabetes.46.11.1782

  10. Wilson, B A

    • A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism. Diabetes November 1997 46:1743-1748; doi:10.2337/diabetes.46.11.1743

  11. Wojtaszewski, J F

    • Insulin signaling in human skeletal muscle: time course and effect of exercise. Diabetes November 1997 46:1775-1781; doi:10.2337/diabetes.46.11.1775

  12. Wolzt, M

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  13. Woods, S C

    • Central leptin stimulates corticosterone secretion at the onset of the dark phase. Diabetes November 1997 46:1911-1914; doi:10.2337/diabetes.46.11.1911

Y

  1. Yao, F

    • The Gln223Arg and Lys656Asn polymorphisms in the human leptin receptor do not associate with traits related to obesity. Diabetes November 1997 46:1898-1900

  2. Yokoyama, H

    • Immunohistochemical quantification of heparan sulfate proteoglycan and collagen IV in skeletal muscle capillary basement membranes of patients with diabetic nephropathy. Diabetes November 1997 46:1875-1880; doi:10.2337/diabetes.46.11.1875

Z

  1. Zanaschka, G

    • Renal and ocular hemodynamic effects of insulin. Diabetes November 1997 46:1868-1874; doi:10.2337/diabetes.46.11.1868

  2. Zhu, M

    • Impaired beta-cell function and deposition of fat droplets in the pancreas as a consequence of hypertriglyceridemia in OLETF rat, a model of spontaneous NIDDM. Diabetes November 1997 46:1718-1724; doi:10.2337/diabetes.46.11.1718

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement